Cubist Pharmaceuticals, Inc. President and CEO Michael Bonney Honored by Massachusetts Biotechnology Council, Inc. with its 2010 Innovative Leadership Award
LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that its President and CEO Michael Bonney will be honored with the second annual Massachusetts Biotechnology Council (MassBio) Innovative Leadership Award. Mr. Bonney will receive this recognition at an awards luncheon at the MassBio Annual Meeting on March 31st at the Seaport World Trade Center in Boston.